{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-25-039777","form_type":"8-K","ticker":"CI","cik":"0001739940","company_name":"Cigna Group","filed_at":"2025-10-30T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.289484+00:00","generated_at":"2026-05-17T01:23:12.532025+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Cigna Q3 revenue up 10% to $69.7B, adjusted EPS $7.83, reaffirms FY2025 guidance","bullets":["Revenue $69.7B (+10% YoY); GAAP net income $1.9B ($6.98 EPS) vs $0.7B ($2.63) in Q3 2024.","Adjusted EPS $7.83 vs $7.51 YoY; reaffirms FY2025 adjusted EPS outlook at least $29.60.","Evernorth segment revenue +15%, adj income +1%; Cigna Healthcare rev -18% due to HCSC divestiture.","Announced new rebate-free pharmacy benefit model to lower costs and improve transparency."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-25-039777","json":"https://secwatch.observer/filing/0001140361-25-039777.json","markdown":"https://secwatch.observer/filing/0001140361-25-039777.md","text":"https://secwatch.observer/filing/0001140361-25-039777.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1739940/000114036125039777/0001140361-25-039777-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1739940/000114036125039777/ef20057735_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T01:23:12.532025+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}